Interaction of pyruvate kinase with isatin and deprenyl

Biomeditsinskaya Khimiya

Volumn 52, Issue 4, 2006, Pages 413-418

  Buneeva, O A ^a   Gnedenko, O V ^a   Medvedeva, M V ^b   Ivanov, Yu D ^a   Glover, V ^c   Medvedev, A E ^a  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Deprenyl; Isatin; Isatin binding proteins; Non glycolytic functions; Pyruvate kinase

Indexed keywords

EID: 33749514805     PISSN: 23106905     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Kayne F.J., Price N.C. (1973) Arch. Biochem. Biophys., 159, 292-296.
2. Tsutsumi H., Tani K., Fujii H., Miwa S. (1988) Genomics., 2, 86-89.
3. Yamada K., Noguchi T. (1999) Biochem. J., 337, 1-11.
4. Nagy E., Rigby W.F. (1995) J. Biol. Chem., 270, 2755-2763.
5. Evguenieva-Hackenberg E., Schiltz E., Klug G. (2002) J. Biol. Chem., 277, 46145-46150.
6. Tatton W., Chalmers-Redman R., Tatton N. (2003) J. Neural Transm., 110, 509-515.
7. Berry M.D. (2004) J. Psychiatry Neurosci., 29, 337-345.
8. Vértessy B.G., Bánkfalvi D., Kovács J., Löw P., Lehotzky A., Ovádi J. (1999) Biochem. Biophys. Res. Commun., 254, 420-435.
9. Kovács J., Löw P., Pacz A., Horvath I., Olah J., Ovádi J. (2003) J. Biol. Chem., 278, 7126-7130.
10. Medvedev A., Igosheva N., Crumeyrolle-Arias M., Glover V. (2005) Stress, 8(3), 175-183.
11. Medvedev A.E., Glover V. (2004) Neurotoxicology, 25, 185-192.
12. Medvedev A., Buneeva O., Gnedenko O., Fedchenko V., Medvedeva M., Ivanov Yu., Glover V., Sandler M. (2006) J. Neural Transm. 2006, Suppl.
13. Carlile G.W., Chalmers-Redman R.M.E., Tatton N.A., Pong A., Borden K.L.B., Tatton W.G. (2000) Mol. Pharmacol., 57, 2-12.
14. Kragten E., Lalande I., Zimmermann K., Roggo S., Schindler P., Muller D., van Oostrum J., Waldmeier P., Furst P. (1998) J. Biol. Chem., 273, 5821-5828.
15. Scopes R.K., Stoter A. (1982) Methods Enzymol., 90 (Pt E), 479-490.
16. Medvedev A.E., Clow A., Sandler M., Glover V. (1996) Biochem. Pharmacol., 52, 385-391.
17. Medvedev A., Crumeyrolle-Arias M., Cardona A., Sandler M., Glover V. (2005) Brain Res., 1042, 119-124.
18. Crumeyrolle-Arias M., Medvedev A., Cardona A., Barritault D., Glover V. (2003) J. Neurochem., 84, 618-620.
19. Veselovsky A.V., Ivanov A.S., Medvedev A.E. (2004) Neurotoxicology, 25, 37-46.
20. Hubalek F., Binda C., Khalil A., Li M., Mattevi A., Castagnoli N., Edmondson D.E. (2005) J. Biol. Chem., 280, 15761-15766.
21. Binda C., Li M., Hubalek F., Restelli N., Edmondson D.E., Mattevi A. (2003) Proc. Natl. Acad. Sci. USA, 100, 9750-9755.
22. Medvedev A.E., Abakumova O. Yu., Podobed O.V., Tsvetkova T.A., Sandler M., Glover V. (2001) Life Sci., 69, 1783-1790.
23. Telegdy G., Adamik A., Glover V. (2000) Brain Res. Bull., 53, 367-370.
24. Pataki I., Adamik A., Telegdy G. (2000) Peptides, 21, 373-377.
25. Lonardo G., Cerbai E., Casini S., Giunti G., Bonacchi M., Battaglia F., Fiorani B., Stefano P.L., Sani G., Mugelli A. (2004) Cardiovasc. Res., 63, 528-536.
26. Potter D.E., Russell K.R., Manhiani M. (2004) J. Pharmacol. Exp. Ther., 309, 548-553.
27. Medvedev A., Byssygina O., Pyatakova N., Glover V., Severina I.S. (2002) Biochem. Pharmacol., 63, 763-766.
28. Melega W.P., Cho A.K., Schmitz D., Kuczenski R., Segal D.S. (1999) J. Pharmacol. Exper. Ther., 288, 752-758.
29. Shimizu T., Uehara T., Nomura Y. (2004) J. Neurochem., 91, 167-175.